TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming.

Area of Science:

• Cardiovascular Biology
• Stem Cell Biology
• Molecular Cardiology

Background:

• Direct cardiac reprogramming aims to regenerate heart muscle by converting fibroblasts into cardiomyocytes.
• Current methods using standard cocktails yield insufficient functional human induced cardiomyocytes.
• The molecular mechanisms governing efficient cardiac reprogramming remain poorly understood.

Purpose of the Study:

• To identify novel factors that enhance direct cardiac reprogramming of human fibroblasts into functional cardiomyocytes.
• To elucidate the role of TBX20 in cardiac cell fate conversion and cardiomyocyte maturation.

Main Methods:

• Transcriptomic comparison between human induced cardiomyocytes and native cardiomyocytes.
• Addition of TBX20 to the MGT133 reprogramming cocktail (MEF2C, GATA4, TBX5, miR-133).
• Comprehensive analyses including transcriptomics, chromatin occupancy, and epigenomics.

Main Results:

• TBX20 was identified as a critical gene not activated by the standard MGT133 cocktail.
• The MGT+TBX20 cocktail significantly improved cardiac reprogramming efficiency and cardiomyocyte function.
• Enhanced human induced cardiomyocytes exhibited improved beating, calcium handling, mitochondrial respiration, and contractility.

Conclusions:

• TBX20 acts synergistically with MGT factors to activate cardiac enhancers, promoting efficient cell fate conversion.
• TBX20-enhanced reprogramming yields human induced cardiomyocytes with superior functional characteristics, including contractility and mitochondrial activity.
• This strategy holds potential for developing improved cell-based therapies for heart disease.